An observational study in Radial Keratotomy in Keratoconus Cases, sponsored by Nisa Hastanesi. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-06-18.
Sponsored by Nisa Hastanesi · Observational
Keratoconus is a progressive ectatic disorder that steepens the cornea resulting in a conical shape. Radial Keratotomy can provide an optical rehabilitation by its flattening effect. It can also halt the progression of disease owing to fibrotic activation in perpendicular corneal incisions.
307 studies on the registry are indexed under Keratoconus; 56 are open to participants now.
This study's enrollment of 36 is below the median of 130 across 94 observational studies indexed under Keratoconus.
Browse Keratoconus studies →This is the only study on the registry with Nisa Hastanesi as lead sponsor.
Counted across the registry records on this site, refreshed daily.
mild to moderate keratoconus cases
Exclusion Criteria:
keratoconus with a central corneal thickness (CCT) over 400µm, poor corrected visual acuity (≤0.4 at Snellen visual acuity charts), contact lens intolerance, no apical scarring, no ocular or systemic problem other than keratoconus
Procedure: radial keratotomy
outcome measures: uncorrected and best spectacle corrected visual acuity, keratometer readings
Preoperative and postoperative uncorrected visual acuity, best spectacle corrected visual acuity, and keratometer readings will be reviewed retrospectively. As reviewed follow up time range is 12 to 52 months, time frame is assessed as " 12 to 52 months"
Time frame: after surgery - 12 to 52 months
This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.